Johnson & Johnson (J&J) says it is making good progress with ongoing restructuring of its medical device business, but the company still is considering various options for its diabetes unit, including potential partnerships or divestitures.
The world’ largest healthcare products manufacturer reported that global medical device sales grew 3 percent over the same period last year to $6.3 billion for the first quarter of 2017. United States Domestic and International sales rose 2.2 percent and 3.8 percent, respectively. Results were driven by strong sales of electrophysiology products in the Cardiovascular business, ACUVUE contact lenses in the Vision Care business, and …
Read the full article at: https://www.meddeviceonline.com/doc/j-j-making-good-progress-with-restructuring-mulling-various-options-for-diabetes-business-0001